Skip to content

Clinical trials

Terminated Observational Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Observational Status: Terminated Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20073
20081
20095
20103
20113
20122
20131
20158
20166
20175
20184
20191
20202
20216
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Addario Lung Cancer Medical Institute3
Stanford University3
Vanderbilt-Ingram Cancer Center3
Washington University School of Medicine3
Breathe BioMedical Inc2
University of Maryland, Baltimore2
AIDS Malignancy Consortium1
Abramson Cancer Center at Penn Medicine1
Alaunos Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung59
Lung Neoplasms22
Breast Neoplasms6
Small Cell Lung Carcinoma6
Pancreatic Neoplasms5
Colonic Neoplasms4
Colorectal Neoplasms4
Carcinoma, Ovarian Epithelial3
Fallopian Tube Neoplasms3
Head and Neck Neoplasms3

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.